Stock·NASDAQ·Technology
Strategy Inc. (MSTR)
- Market cap
- $57.94B
- Dividend yield
- 0.00%
- Street target
- $215.00median of 16 analysts
- 52-week range
- $81.81 $306.16
The short version
Where MSTR stands today, in four lines, and what CleaRank Financial AI makes of it.
MSTR at a glance
Strategy Inc. (MSTR): Hold, 42/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($134.92 and $135.60).
- Earnings MSTR beat estimates in 1 of its last 3 quarters, yet fell the next day after every one of them.
- Insiders Insiders sold $144.3M and bought $779K over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
MSTR (Strategy Inc.) carries a CleaRank rating of Hold and a model score of 42/100.
Analysts' views add the most to that score, with 15 of 16 rating the stock a buy and a median target 57.1% above the price. Valuation drags the score down the most: there is no meaningful P/E because the company lost money, and the P/S of 128.55 sits 1,591.4% above the sector median. The trend is up, with the price 1.41% above its 50-day average of $134.92 and 0.90% above its 200-day average of $135.60. The price has fallen 51.79% over the past year.
Only on CleaRank
Figures we compute ourselves from MSTR's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $136.83 is 1.4% above the 50-day simple moving average of $134.92.Price above its 200-day average ›
The price is 0.9% above the 200-day simple moving average of $135.60.50-day average above the 200-day ›
The 50-day average ($134.92) is 0.5% below the 200-day average ($135.60), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 25% of its 52-week range, between $81.81 and $306.16.
MSTR share price
Pick a period: each tab shows how far MSTR has moved over it, to the last close.
Today's trading
Where MSTR sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/3P/S below the sector median ›
The price-to-sales ratio of 128.55 is 1,591.5% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $-31.4B on revenue of $498.3M, a net margin of -6,294.2%.Beat estimates in most recent reports ›
MSTR beat the EPS estimate in 1 of its last 3 reports.
Key statistics
The headline figures for MSTR.
As of October 17, 2026, MSTR trades at $136.83, with a market value of $57.94B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of MSTR's valuation, growth and risks.
A P/E cannot be read for Strategy Inc. (MSTR): it is not meaningful, because the company lost money over the last 12 months. MSTR trades at 128.55 times its sales, 1,591.4% above the sector median of 7.6. For scale, MSTR carries a market capitalisation of $57.9B and trailing earnings of -$93.26 a share.
MSTR is losing money: its net margin and operating margin are both -6.00%. Revenue growth of 6.90% leaves it 17.3 percentage points slower than the sector median of 24.2%. Return on equity stands at -63.56%, below the sector median of 13.4%. Debt-to-equity of 0.15 completes the balance sheet picture.
Strategy Inc. (MSTR) reported -$24.45 a share on the July 30, 2026 report, against a $3.07 estimate, missing the estimate by 896.42%. Investors reacted in the next session, when the stock fell 4.56%.
MSTR beat estimates in 1 of the last 3 reports, and the stock still fell in the first session after that beat. The biggest reaction among the earlier reports came after the July 31, 2025 report: EPS beat the estimate by 51.40%, yet the stock fell 8.77%. For this fiscal year, analysts' average EPS estimate is -$23.30, and for next year it is $13.41.
Strategy Inc. (MSTR) is a stock to plan around day to day: it has moved 5.04% on an average session. The price is also 55.31% below its 52-week high of $306.16, so the distance from that peak is large.
MSTR against the Technology sector
How MSTR compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, MSTR trades at 128.55x, far above the sector average of 7.60x.
Return vs XLK: Since May 6, 2025, MSTR has lost 64.5% against a gain of 71.7% for XLK.
Performance against XLK
MSTR and the Technology sector fund over the same days.
Revenue and earnings
How much MSTR sells, and how much of it becomes profit.
Revenue growth: Revenue grew 3.0% in FY2025 to $477M, from $463M a year earlier.
Profit margin: The net margin was -806.3% in FY2025, down from -251.7% the year before.
Loss-making: MSTR lost $3.8B in FY2025.
Earnings reality check
Did MSTR beat what analysts expected, and how did the stock react?
Earnings record: MSTR beat the analyst estimate in 1 of the last 3 quarters.
Market reaction: The stock fell in the first session after 1 of those 1 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 30, 2026after close | $3.07 | -$24.45 | -896.42% | -4.56% | -0.91% |
| May 5, 2026after close | -$15.33 | -$38.25 | -149.51% | -0.04% | -1.33% |
| Jul 31, 2025after close | $21.48 | $32.52 | +51.40% | -8.77% | +0.04% |
As of October 17, 2026, MSTR has beaten the analyst EPS estimate in 1 of its last 3 reported quarters and fell in the first trading session after it; its latest report, on July 30, 2026, came in 896.42% below the estimate and the stock moved -4.56% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 42.6, in neutral territory.RSI above 50 ›
An RSI of 42.6 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of MSTR
The score, the reasoning behind it, and what could move the price next.
At $136.83, Strategy Inc. (MSTR) sits in an uptrend, trading 1.41% above its 50-day average of $134.92 and 0.90% above its 200-day average of $135.60. The stock is near the bottom of its 52-week range: the price is 67.25% above the low of $81.81 and 55.31% below the high of $306.16. The averages still lag the price, since the 50-day sits 0.50% below the 200-day.
The longer record is weaker than the recent run of gains. Over the past year the price fell 51.79%, even though it rose 44.26% over three months and 8.44% over the past month. In the last session, which saw the price fall 9.56%, volume came in 61.0% above its average. The 14-day RSI sits at 42.6, which is neutral, and the MACD line is positive.
Rating reaffirmed ›
Barclays kept its Overweight rating on October 9, 2026.
Source: Analyst action, Barclays, October 9, 2026
Earnings miss ›
The July 30, 2026 report missed the EPS estimate by 896.42%, and the share price fell 4.56% in the first session after it.
Source: Earnings report, July 30, 2026
- The two levels nearest the price are the 20-day EMA at $149.71, above it, and the 200-day SMA at $135.60, below it.
- The 14-day RSI is 42.6, which is neutral, and the MACD line is positive. Readings above 70 or below 30 point to stretched momentum.
- The share price fell 4.56% in the first session after the July 30, 2026 report. MSTR beat estimates in 1 of the last 3 reports.
The uptrend rests on MSTR staying above its 50-day average at $134.92 and its 200-day average at $135.60; a close below the 200-day would be the first crack in it. On a pullback, the first level the price would meet is the 200-day SMA at $135.60.
Strategy Inc. (MSTR) has one nearby level on the upside: the 20-day EMA at $149.71, which sits above the price and would be the first level a rise meets.
Technical indicators
Momentum and trend for MSTR, from its daily closes.
As of October 17, 2026, with MSTR at $136.83, its 14-day RSI is 42.6 (neutral territory), its 50-day simple moving average is $134.92 and its 200-day is $135.60.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What MSTR moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, MSTR's 1-year correlation of daily returns is +0.47 with S&P 500 (SPY), +0.50 with Nasdaq 100 (QQQ), +0.81 with Bitcoin (BTC) and +0.22 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
15 of 16 analysts rate it a buy or strong buy, 1 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $215.00 is 57.1% above the price.More buy ratings than three months ago ›
15 of 16 rate it a buy now, against 14 of 15 three months ago.
MSTR Wall Street View
12-month price targets
The price, $136.83, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | Barclays | Maintains | Overweight |
| Oct 2, 2026 | Citigroup | Maintains | Buy |
| Sep 22, 2026 | B. Riley Securities | Maintains | Buy |
| Sep 15, 2026 | Barclays | Maintains | Overweight |
| Sep 8, 2026 | Canaccord Genuity | Maintains | Buy |
| Sep 3, 2026 | B. Riley Securities | Maintains | Buy |
As of October 17, 2026, 16 Wall Street analysts cover MSTR: 15 rate it a buy or strong buy, 1 a hold and 0 a sell or strong sell. Their 12-month price targets range from $165.00 to $435.00, with a median of $215.00, 57.1% above the price of $136.83.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
MSTR trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
MSTR moves about 5.0% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much MSTR tends to move, against the market and on its own.
The long record
MSTR's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 5.04% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 89.2%, from February 2021 to December 2022, regained by March 2024.Most 1-year holds ended higher ›
55% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $79,622, against $42,055 in the S&P 500 (SPY).
MSTR Drawdowns & Recovery
As of October 17, 2026, MSTR's worst peak-to-trough fall over the last 10 years with dividends reinvested was -89.2% (February 2021 to December 2022); it regained that peak by March 2024, 15 months after the low, and 55% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into MSTR in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: MSTR beat the S&P 500 over this period: $79,622 against $42,055.
A $10,000 investment in MSTR in October 2016 would be worth about $79,622 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to MSTR, and which have not.
Strongest month, July: an average of +16.74%, up in 8 of 10 years.
Weakest month, May: an average of -4.10%, up in 3 of 10 years.
This month, October: has averaged +15.35%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, MSTR's strongest calendar month has been July (average +16.74%, up in 8 of 10 years) and its weakest May (average -4.10%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in MSTR, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in MSTR today could grow to about $27,590 by 2036 in the base case, with a 90th-percentile outcome near $209,314 and a 10th-percentile outcome around $3,637. Projections are statistical simulations, not guarantees.
MSTR Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $205 for MSTR by 2030 in the base case, from $137 today (1.5x over 4 years). The 10th-percentile path ends near $57.00. These are outcomes of a Monte Carlo simulation run on MSTR's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $79.79 | $151 | $287 | |
| 2028 | $67.73 | $168 | $415 | |
| 2029 | $61.15 | $186 | $563 | |
| 2030 | $57.00 | $205 | $740 | |
| 2031 | $54.23 | $227 | $952 |
Method: a lognormal simulation of MSTR's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. MSTR is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
MSTR insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $779K on the open market and sold $144.3M.
As of October 17, 2026, MSTR insiders reported 71 open-market sales worth $144.3M and 1 open-market purchase worth $779K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Jarrod Michael Patten
Director
|
Sell | 475 | $81.2K |
| Sep 22, 2026 | Jarrod Michael Patten
Director
|
Option | 475 | $8.7K |
| Sep 21, 2026 | Jarrod Michael Patten
Director
|
Sell | 1.4K | $238.4K |
| Sep 21, 2026 | Jarrod Michael Patten
Director
|
Option | 1.4K | $26.0K |
| Aug 27, 2026 | Jarrod Michael Patten
Director
|
Sell | 1.9K | $240.5K |
| Aug 27, 2026 | Jarrod Michael Patten
Director
|
Option | 1.9K | $33.7K |
| Aug 25, 2026 | Jarrod Michael Patten
Director
|
Sell | 3.7K | $461.0K |
| Aug 25, 2026 | Jarrod Michael Patten
Director
|
Option | 3.7K | $67.5K |
| Aug 7, 2026 | Jarrod Michael Patten
Director
|
Sell | 3.8K | $389.1K |
| Aug 7, 2026 | Jarrod Michael Patten
Director
|
Option | 3.8K | $69.3K |
| Jul 27, 2026 | Jarrod Michael Patten
Director
|
Sell | 3.9K | $372.3K |
| Jul 27, 2026 | Jarrod Michael Patten
Director
|
Option | 3.9K | $71.1K |
| Jul 22, 2026 | Jarrod Michael Patten
Director
|
Sell | 1.3K | $125.0K |
| Jul 22, 2026 | Jarrod Michael Patten
Director
|
Option | 1.3K | $22.8K |
| Jun 23, 2026 | Jarrod Michael Patten
Director
|
Sell | 1.5K | $159.1K |
| Jun 23, 2026 | Jarrod Michael Patten
Director
|
Option | 1.5K | $27.4K |
| Jun 17, 2026 | Jarrod Michael Patten
Director
|
Sell | 1.5K | $182.0K |
| Jun 17, 2026 | Jarrod Michael Patten
Director
|
Option | 1.5K | $27.4K |
| Jun 15, 2026 | Jarrod Michael Patten
Director
|
Sell | 1.5K | $201.0K |
| Jun 15, 2026 | Jarrod Michael Patten
Director
|
Option | 1.5K | $27.4K |
| Jun 9, 2026 | Phong Quoc Le
Chief Executive Officer
|
Sell | 5.5K | $683.8K |
| Jun 9, 2026 | Andrew Kang
Chief Financial Officer
|
Sell | 1.9K | $241.4K |
| Jun 9, 2026 | Jeanine J. Montgomery
Officer
|
Sell | 354 | $43.8K |
| Jun 8, 2026 | Andrew Kang
Chief Financial Officer
|
Grant | 4.3K | - |
| Jun 8, 2026 | Phong Quoc Le
Chief Executive Officer
|
Grant | 11.9K | - |
| Jun 8, 2026 | Jeanine J. Montgomery
Officer
|
Grant | 1.1K | - |
| Jun 5, 2026 | Phong Quoc Le
Chief Executive Officer
|
Sell | 93.7K | $11.1M |
| Jun 5, 2026 | Andrew Kang
Chief Financial Officer
|
Sell | 33.1K | $3.9M |
| Jun 3, 2026 | Andrew Kang
Chief Financial Officer
|
Grant | 68.1K | - |
| Jun 3, 2026 | Phong Quoc Le
Chief Executive Officer
|
Grant | 190.7K | - |
| May 29, 2026 | Jarrod Michael Patten
Director
|
Sell | 22.3K | $3.4M |
| May 29, 2026 | Brian P Brooks
Director
|
Grant | 406 | - |
| May 29, 2026 | Jane A Dietze
Director
|
Grant | 406 | - |
| May 29, 2026 | Stephen X Graham
Director
|
Grant | 406 | - |
| May 29, 2026 | Jarrod Michael Patten
Director
|
Grant | 406 | - |
| May 29, 2026 | Jarrod Michael Patten
Director
|
Option | 22.3K | $414.2K |
| May 29, 2026 | Carl John Rickertsen
Director
|
Grant | 406 | - |
| May 29, 2026 | Gregg Winiarski
Director
|
Grant | 406 | - |
| May 26, 2026 | Jarrod Michael Patten
Director
|
Sell | 1.3K | $206.6K |
| May 26, 2026 | Jarrod Michael Patten
Director
|
Option | 1.3K | $23.3K |
| May 20, 2026 | Jarrod Michael Patten
Director
|
Sell | 5.3K | $875.1K |
| May 20, 2026 | Jarrod Michael Patten
Director
|
Option | 5.3K | $97.9K |
| May 19, 2026 | Andrew Kang
Chief Financial Officer
|
Sell | 5.6K | $927.9K |
| May 19, 2026 | Andrew Kang
Chief Financial Officer
|
Sell | 5.6K | $927.9K |
| May 18, 2026 | Andrew Kang
Chief Financial Officer
|
Grant | 12.5K | - |
| May 14, 2026 | Jarrod Michael Patten
Director
|
Sell | 1.5K | $286.3K |
| May 14, 2026 | Jarrod Michael Patten
Director
|
Option | 1.5K | $28.0K |
| May 11, 2026 | Jarrod Michael Patten
Director
|
Sell | 3.8K | $713.6K |
| May 11, 2026 | Jarrod Michael Patten
Director
|
Option | 3.8K | $70.0K |
| May 4, 2026 | Jarrod Michael Patten
Director
|
Sell | 2.0K | $366.5K |
| May 4, 2026 | Jarrod Michael Patten
Director
|
Option | 2.0K | $37.3K |
| May 1, 2026 | Jarrod Michael Patten
Director
|
Sell | 4.0K | $676.7K |
| May 1, 2026 | Jarrod Michael Patten
Director
|
Option | 4.0K | $74.6K |
| Apr 22, 2026 | Jarrod Michael Patten
Director
|
Sell | 2.0K | $356.3K |
| Apr 22, 2026 | Jarrod Michael Patten
Director
|
Option | 2.0K | $37.3K |
| Apr 21, 2026 | Jarrod Michael Patten
Director
|
Sell | 2.0K | $336.4K |
| Apr 21, 2026 | Jarrod Michael Patten
Director
|
Option | 2.0K | $37.3K |
| Apr 13, 2026 | Jarrod Michael Patten
Director
|
Sell | 3.4K | $444.2K |
| Apr 13, 2026 | Jarrod Michael Patten
Director
|
Option | 3.4K | $63.4K |
| Apr 9, 2026 | Jarrod Michael Patten
Director
|
Sell | 1.9K | $248.1K |
| Apr 9, 2026 | Jarrod Michael Patten
Director
|
Option | 1.9K | $35.4K |
| Apr 8, 2026 | Jarrod Michael Patten
Director
|
Sell | 2.1K | $270.7K |
| Apr 8, 2026 | Jarrod Michael Patten
Director
|
Option | 2.1K | $39.2K |
| Apr 1, 2026 | Jarrod Michael Patten
Director
|
Sell | 1.4K | $172.7K |
| Apr 1, 2026 | Jarrod Michael Patten
Director
|
Option | 1.4K | $26.1K |
| Mar 30, 2026 | Jarrod Michael Patten
Director
|
Sell | 700 | $89.6K |
| Mar 30, 2026 | Jarrod Michael Patten
Director
|
Option | 700 | $13.1K |
| Mar 26, 2026 | Jarrod Michael Patten
Director
|
Sell | 700 | $96.2K |
| Mar 26, 2026 | Jarrod Michael Patten
Director
|
Option | 700 | $13.1K |
| Mar 24, 2026 | Phong Quoc Le
Chief Executive Officer
|
Sell | 3.3K | $456.4K |
| Mar 24, 2026 | Andrew Kang
Chief Financial Officer
|
Sell | 2.4K | $328.3K |
| Mar 24, 2026 | Jeanine J. Montgomery
Officer
|
Sell | 470 | $65.0K |
| Mar 23, 2026 | Andrew Kang
Chief Financial Officer
|
Grant | 5.3K | - |
| Mar 23, 2026 | Phong Quoc Le
Chief Executive Officer
|
Grant | 7.3K | - |
| Mar 23, 2026 | Jeanine J. Montgomery
Officer
|
Grant | 1.6K | - |
| Mar 12, 2026 | Phong Quoc Le
Chief Executive Officer
|
Sell | 2.0K | $279.2K |
| Mar 12, 2026 | Andrew Kang
Chief Financial Officer
|
Sell | 916 | $125.7K |
| Mar 12, 2026 | Jeanine J. Montgomery
Officer
|
Sell | 260 | $35.7K |
| Mar 11, 2026 | Andrew Kang
Chief Financial Officer
|
Grant | 2.1K | - |
| Mar 11, 2026 | Phong Quoc Le
Chief Executive Officer
|
Grant | 4.5K | - |
| Mar 11, 2026 | Jeanine J. Montgomery
Officer
|
Grant | 787 | - |
| Jan 12, 2026 | Carl John Rickertsen
Director
|
Buy | 5.0K | $779.4K |
| Dec 19, 2025 | Brian P Brooks
Director
|
Grant | 686 | - |
| Dec 19, 2025 | Jane A Dietze
Director
|
Grant | 686 | - |
| Dec 19, 2025 | Andrew Kang
Chief Financial Officer
|
Grant | 1.8K | - |
| Dec 19, 2025 | Gregg Winiarski
Director
|
Grant | 686 | - |
| Nov 19, 2025 | Wei-Ming Shao
General Counsel
|
Sell | 5.2K | $1.0M |
| Nov 19, 2025 | Wei-Ming Shao
General Counsel
|
Option | 5.2K | $359.4K |
| Nov 18, 2025 | Jeanine J. Montgomery
Officer
|
Sell | 43 | $9.0K |
| Nov 17, 2025 | Wei-Ming Shao
General Counsel
|
Sell | 5.2K | $1.0M |
| Nov 17, 2025 | Jeanine J. Montgomery
Officer
|
Grant | 100 | - |
| Nov 17, 2025 | Wei-Ming Shao
General Counsel
|
Option | 5.2K | $359.4K |
| Nov 13, 2025 | Wei-Ming Shao
General Counsel
|
Sell | 7.9K | $1.8M |
| Nov 13, 2025 | Wei-Ming Shao
General Counsel
|
Option | 27.9K | $1.4M |
| Nov 11, 2025 | Wei-Ming Shao
General Counsel
|
Sell | 10.7K | $2.6M |
| Nov 11, 2025 | Wei-Ming Shao
General Counsel
|
Option | 10.7K | $737.4K |
| Oct 7, 2025 | Wei-Ming Shao
General Counsel
|
Sell | 30.0K | $10.7M |
| Oct 7, 2025 | Wei-Ming Shao
General Counsel
|
Option | 30.0K | $1.2M |
| Sep 18, 2025 | Wei-Ming Shao
General Counsel
|
Sell | 10.0K | $3.6M |
| Sep 18, 2025 | Wei-Ming Shao
General Counsel
|
Option | 10.0K | $404.6K |
| Aug 7, 2025 | Andrew Kang
Chief Financial Officer
|
Sell | 18.8K | $7.4M |
| Aug 7, 2025 | Andrew Kang
Chief Financial Officer
|
Option | 18.8K | $370.2K |
| Aug 5, 2025 | Andrew Kang
Chief Financial Officer
|
Sell | 6.3K | $2.4M |
| Aug 5, 2025 | Andrew Kang
Chief Financial Officer
|
Option | 6.3K | $123.4K |
| Jul 14, 2025 | Wei-Ming Shao
General Counsel
|
Sell | 10.9K | $4.9M |
| Jul 14, 2025 | Wei-Ming Shao
General Counsel
|
Option | 10.9K | $441.0K |
| Jul 11, 2025 | Jeanine J. Montgomery
Officer
|
Sell | 43.8K | $18.8M |
| Jul 11, 2025 | Wei-Ming Shao
General Counsel
|
Sell | 10.0K | $4.3M |
| Jul 11, 2025 | Jeanine J. Montgomery
Officer
|
Option | 43.8K | $2.3M |
| Jul 11, 2025 | Wei-Ming Shao
General Counsel
|
Option | 10.0K | $404.6K |
| Jul 10, 2025 | Wei-Ming Shao
General Counsel
|
Sell | 52.5K | $21.4M |
| Jul 10, 2025 | Wei-Ming Shao
General Counsel
|
Option | 52.5K | $1.8M |
| Jun 18, 2025 | Phong Quoc Le
Chief Executive Officer
|
Grant | 8.4K | - |
| Jun 6, 2025 | Phong Quoc Le
Chief Executive Officer
|
Sell | 5.3K | $2.0M |
| Jun 6, 2025 | Andrew Kang
Chief Financial Officer
|
Sell | 1.9K | $703.0K |
| Jun 6, 2025 | Wei-Ming Shao
General Counsel
|
Sell | 1.7K | $637.1K |
| Jun 6, 2025 | Jeanine J. Montgomery
Officer
|
Sell | 340 | $127.3K |
| Jun 5, 2025 | Andrew Kang
Chief Financial Officer
|
Grant | 4.3K | - |
| Jun 5, 2025 | Phong Quoc Le
Chief Executive Officer
|
Grant | 11.9K | - |
| Jun 5, 2025 | Jeanine J. Montgomery
Officer
|
Grant | 1.1K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.